Just-released results from international trials indicate a potential vaccine, designed to protect against nine HPV strains, might be the next step in cervical cancer protection. In the pivotal Phase III efficacy study, the investigational 9-valent HPV vaccine prevented approximately 97% of cervical, vaginal, and vulvar pre-cancers caused by HPV types 31, 33, 45, 52, and 58.
More women are now choosing long-acting reversible contraceptive (LARC) methods, such as intrauterine devices (IUDs) and the subdermal contraceptive implant. The number of women using LARC methods rose from 2.4% in 2002 to 8.5% in 2009. Read More
A new American College of Obstetricians and Gynecologists committee opinion has endorsed use of the U.S. Selected Practice Recommendations for Contraceptive Use, 2013 (US SPR) in counseling patients about how to most effectively use current birth control methods.
Make the first reproductive health visit for a young teen a successful one by using the HEEADSSS (Home environment, Education and employment, Eating, peer-related Activities, Drugs, Sexuality, Suicide/depression, and Safety from injury and violence) method of interviewing in performing a psychosocial review of systems. Read More
One problem that policymakers are confronting as they implement the Affordable Care Act (ACA) is that even if people gain health insurance coverage, they might not always be willing to use it.